Forterre Gael has filed 22 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 5251 shares of VOLITIONRX LTD ($VNRX) on March 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 5251 | $0.19 | 368,838.0000 | 122,801,572 | 1.40% | 0.00% |
| March 1, 2026 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 2283 | $0.21 | 374,089.0000 | 122,801,572 | 0.61% | 0.00% |
| Feb. 26, 2026 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 149000 | $0.00 | 376,372.0000 | 122,801,572 | 65.53% | 0.12% |
| Feb. 1, 2026 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 2010 | $0.29 | 227,372.0000 | 122,801,572 | 0.88% | 0.00% |
| Jan. 22, 2026 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 38100 | $0.00 | 229,382.0000 | 122,801,572 | 19.92% | 0.03% |
| Nov. 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 1753 | $0.43 | 191,282.0000 | 96,543,744 | 0.91% | 0.00% |
| Oct. 4, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 5389 | $0.65 | 193,035.0000 | 96,543,744 | 2.72% | 0.01% |
| Sept. 28, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 5503 | $0.61 | 198,424.0000 | 96,543,744 | 2.70% | 0.01% |
| Aug. 15, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 9727 | $0.00 | 203,927.0000 | 96,543,744 | 5.01% | 0.01% |
| Aug. 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 2766 | $0.64 | 194,200.0000 | 96,543,744 | 1.40% | 0.00% |
| June 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 1996 | $0.77 | 196,966.0000 | 96,543,744 | 1.00% | 0.00% |
| June 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 6690 | $0.00 | 203,196.0000 | 96,543,744 | 3.40% | 0.01% |
| June 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 4234 | $0.50 | 198,962.0000 | 96,543,744 | 2.08% | 0.00% |
| May 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 3698 | $0.49 | 196,506.0000 | 96,543,744 | 1.85% | 0.00% |
| March 1, 2025 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 5523 | $0.00 | 200,204.0000 | 0 | 2.84% | 0.00% |
| Dec. 1, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 4828 | $0.00 | 194,681.0000 | 0 | 2.54% | 0.00% |
| Oct. 4, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 5433 | $0.88 | 189,853.0000 | 0 | 2.78% | 0.00% |
| Sept. 28, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | F | Common Stock | 4824 | $0.58 | 195,286.0000 | 0 | 2.41% | 0.00% |
| Sept. 1, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 10240 | $0.00 | 200,110.0000 | 0 | 5.39% | 0.00% |
| Aug. 15, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 15250 | $0.00 | 189,870.0000 | 0 | 8.73% | 0.00% |
| June 1, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 8944 | $0.00 | 174,620.0000 | 0 | 5.40% | 0.00% |
| Jan. 24, 2024 | VOLITIONRX LTD | $VNRX | Forterre Gael | Chief Commercial Officer | A | Common Stock | 25925 | $0.00 | 165,676.0000 | 0 | 18.55% | 0.00% |